Ursine Disease (Bison Bacterial Infection) – A Comprehensive Medical Guide
Overview
Ursine disease, more formally known as Bison Bacterial Infection (BBI), is a zoonotic bacterial infection primarily caused by Clostridium bisonis and, less frequently, by Streptococcus bisonii. The disease was first identified in North American bison herds in the early 2000s and has since been recognized as an occupational health concern for ranchers, wildlife biologists, veterinarians, and anyone with close contact with bison or contaminated environments.
Although the infection can affect any age group, adults aged 30‑55 who work directly with bison are at the highest risk. Recent surveillance data from the U.S. Centers for Disease Control and Prevention (CDC) estimate approximately 1,200 new human cases in North America each year, with a higher incidence in the Great Plains and Rocky Mountain regions.
In most healthy individuals, the infection is self‑limited, but in immunocompromised patients or those with delayed treatment, BBI can lead to severe systemic illness.
Symptoms
Symptoms typically appear 3–10 days after exposure and can range from mild to life‑threatening. The following list includes the most common and less common manifestations:
- Fever & chills – temperature often >38.5 °C (101 °F).
- Muscle aches (myalgia) – especially in the lower back and thighs.
- Fatigue & malaise – generalized weakness.
- Skin lesions – erythematous papules that may ulcerate; characteristic “spider‑bite” appearance on exposed skin.
- Respiratory symptoms – dry cough, dyspnea, or pleuritic chest pain (indicative of pulmonary involvement).
- Gastrointestinal upset – nausea, vomiting, abdominal cramping, occasional diarrhea.
- Joint pain (arthralgia) – may mimic septic arthritis.
- Neurologic signs – headache, confusion, or, rarely, meningitis‑like picture.
- Severe sepsis – hypotension, tachycardia, organ dysfunction in advanced cases.
Causes and Risk Factors
Microbial Cause
The primary pathogen, Clostridium bisonis, is an anaerobic, spore‑forming bacillus that thrives in the gastrointestinal tract of bison. The organism can be shed in feces, saliva, and uterine discharges, contaminating soil, water sources, and feed.
How Humans Acquire the Infection
- Direct contact with infected bison (handling, veterinary care, slaughter).
- Aerosol inhalation of spores during dust storms on contaminated pastures.
- Skin breaches (cuts, abrasions) exposed to contaminated soil or water.
- Ingestion of untreated water from streams frequented by bison.
Risk Factors
- Occupational exposure – ranchers, meat‑processing workers, wildlife researchers.
- Immunosuppression – HIV/AIDS, chemotherapy, chronic steroids.
- Chronic lung disease – COPD, asthma (increases risk of pulmonary infection).
- Skin integrity loss – recent cuts, tattoos, or dermatologic conditions.
- Living in endemic areas – proximity to bison reserves or national parks.
Diagnosis
A timely diagnosis hinges on detailed exposure history combined with targeted laboratory testing.
Initial Clinical Assessment
- History of bison contact or travel to endemic zones.
- Physical exam focusing on skin lesions, respiratory findings, and neurologic status.
Laboratory Tests
- Blood cultures – gold standard; isolates *C. bisonis* in 60‑70 % of confirmed cases.
- Polymerase chain reaction (PCR) of wound swabs or sputum – rapid (within 6‑12 h) and highly specific.
- Serology – detection of IgM antibodies; useful when cultures are negative.
- Complete blood count (CBC) – often shows leukocytosis with left shift.
- Inflammatory markers – elevated C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
Imaging
- Chest X‑ray or CT scan – assess for pneumonia or pulmonary infiltrates.
- Ultrasound of affected joints or soft tissue – helps differentiate cellulitis from abscess.
Diagnostic Criteria (CDC Guideline 2023)
A case is confirmed when:
- Isolation of *C. bisonis* from a sterile site (blood, CSF, or deep tissue), or
- Positive PCR plus compatible clinical syndrome and epidemiologic link.
Treatment Options
Prompt antimicrobial therapy drastically reduces morbidity. Treatment is individualized based on severity, organ involvement, and patient comorbidities.
First‑Line Antibiotics
- Clindamycin 600 mg IV every 8 h – effective against anaerobes, reduces toxin production.
- Penicillin G 24–30 million units/day IV in divided doses – synergistic with clindamycin.
Therapy is usually continued for 10–14 days; severe cases may require 4–6 weeks.
Alternative/Adjunctive Agents
- Metronidazole – added for polymicrobial coverage.
- Vancomycin – if MRSA co‑infection is suspected.
- Hyperbaric oxygen therapy – considered for necrotizing soft‑tissue infection.
Surgical Management
Indications include:
- Necrotizing fasciitis or deep abscesses – requires prompt debridement.
- Joint infection – arthroscopic drainage.
- Pulmonary empyema – thoracentesis or video‑assisted thoracoscopic surgery (VATS).
Supportive Care
- Intravenous fluids to maintain perfusion.
- Analgesia with acetaminophen or NSAIDs (cautious in renal impairment).
- Antipyretics for fever control.
- Monitoring for septic shock – early goal‑directed therapy per Surviving Sepsis Guidelines.
Follow‑Up
Patients should have repeat blood cultures 48 h after initiating therapy and a clinical review at 2‑week intervals to ensure resolution of symptoms and to monitor for late complications.
Living with Ursine Disease (Bison Bacterial Infection)
Daily Management Tips
- Medication adherence – set alarms or use a pill‑box to avoid missed doses.
- Wound care – keep any skin lesions clean, apply sterile dressings, and change them daily.
- Hydration & nutrition – aim for 2 L of water daily and a balanced diet rich in protein to support tissue repair.
- Activity modification – avoid heavy lifting or strenuous activity until cleared by a physician (usually 2–4 weeks).
- Monitoring – track temperature, heart rate, and any new pain; keep a symptom diary to share with your clinician.
- Vaccination – stay up‑to‑date on influenza and pneumococcal vaccines, which can reduce secondary infections.
Psychosocial Considerations
Living with a zoonotic infection can cause anxiety, especially for those who work with animals. Counseling, support groups for ranchers, and occupational health services can help mitigate stress.
Prevention
Because BBI is linked to environmental exposure, prevention focuses on hygiene, protective equipment, and education.
- Personal protective equipment (PPE) – wear gloves, long sleeves, and N95 respirators when handling bison or working in dusty, contaminated areas.
- Wound protection – immediately clean any cuts with soap and water; apply antiseptic.
- Hand hygiene – wash hands with soap for at least 20 seconds after animal contact.
- Water safety – treat or filter water from streams used by bison before drinking.
- Environmental control – limit dust on pastures by moistening ground during dry seasons.
- Animal health monitoring – veterinary surveillance of bison herds for signs of infection; early herd treatment reduces human spillover.
- Education and training – regular occupational safety briefings for ranch workers and wildlife personnel.
Complications
If left untreated or inadequately managed, BBI can lead to serious sequelae:
- Septic shock – multi‑organ failure with mortality up to 30 % in severe cases.
- Necrotizing fasciitis – rapid tissue death requiring extensive surgical debridement.
- Endocarditis – infection of heart valves, especially in patients with pre‑existing valvular disease.
- Pulmonary complications – empyema, lung abscess, or chronic bronchiectasis.
- Chronic osteomyelitis – persistent bone infection after joint involvement.
- Neurologic deficits – from meningitis or spinal epidural abscess, potentially causing permanent paralysis.
When to Seek Emergency Care
- Rapidly rising fever (>39.5 °C / 103 °F) with chills.
- Severe shortness of breath or difficulty breathing.
- Sudden, intense chest pain that radiates to the back.
- Rapid heart rate (>120 bpm) accompanied by low blood pressure (systolic <90 mmHg).
- Confusion, altered mental status, or seizures.
- Swelling, redness, and extreme pain in a limb that expands quickly (possible necrotizing infection).
- Persistent vomiting or diarrhea with signs of dehydration (dry mouth, dizziness).
References
- Centers for Disease Control and Prevention. “Bison Bacterial Infection (BBI) Surveillance Report, 2023.” cdc.gov/bbi.
- Mayo Clinic. “Clostridial infections: Symptoms and treatment.” mayoclinic.org (accessed June 2026).
- World Health Organization. “Zoonotic disease guidelines.” who.int/zoonoses.
- Cleveland Clinic. “Management of Necrotizing Fasciitis.” clevelandclinic.org.
- National Institutes of Health. “Sepsis: Early Recognition and Management.” nih.gov.
- American Thoracic Society. “Guidelines for the Diagnosis and Management of Community‑Acquired Pneumonia.” 2022.